Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coding mutations in NUS1 contribute to Parkinson's disease.

Ji-Feng Guo1,2,3,4, Lu Zhang5,6,7, Kai Li1

  • 1Department of Neurology, Xiangya Hospital, Central South University, 410008 Changsha, Hunan, China.

Proceedings of the National Academy of Sciences of the United States of America
|October 24, 2018
PubMed

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nuclear condensates formed by truncated mutant NEK1s impede ribosomal RNA biogenesis and drive motor dysfunction.

Nature communications·2026
Same author

Structural insights into the MLH1-FAN1 interaction reveal an uncharacterized binding interface on MLH1.

Nature communications·2026
Same author

Haplotype-resolved methylomes reveal parent-of-origin DNA methylation imbalance in autism spectrum disorder.

Science advances·2026
Same author

Interpretable Machine Learning Model for Individualized Survival Prediction of Multiple System Atrophy.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Lysine acetyltransferase 8-mediated histone acetylation, regulated by GBA1, is associated with lysosomal function related to α-Synuclein pathology.

Cell death & disease·2026
Same author

Genomic Landscape and Phenotypic Spectrum of Autosomal Recessive Cerebellar Ataxia in China.

Movement disorders : official journal of the Movement Disorder Society·2026
Summary

De novo mutations may contribute to early onset Parkinson's disease (PD). Researchers identified 12 genes with de novo mutations and found NUS1 variants significantly associated with PD, with functional studies supporting its role.

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • Whole-exome sequencing has identified genetic factors in Parkinson's disease (PD).
  • The role of de novo mutations in PD pathogenesis remains largely unexplored.
  • Early onset PD presents unique genetic challenges.

Purpose of the Study:

  • To investigate the contribution of de novo mutations to early onset Parkinson's disease.
  • To identify novel candidate genes associated with PD pathogenesis.
  • To functionally validate the role of candidate genes in PD.

Main Methods:

  • Whole-exome sequencing of 39 early onset PD patients, their parents, and unaffected siblings.
  • Analysis of two independent case-control cohorts (1,852 PD patients/1,565 controls and 3,237 PD patients/2,858 controls).
Keywords:
Parkinson’s diseasede novo mutationsdisease-risk geneexome sequencingneurodegenerative disorders

Related Experiment Videos

  • Functional studies in Drosophila melanogaster to assess the impact of gene loss.

    • Main Results:

    • Identified 12 genes with de novo mutations potentially relevant to PD pathogenesis.
    • NUS1 showed a significantly higher frequency of rare nonsynonymous variants in PD patients compared to controls (P = 1.01E-5, OR = 11.3).
    • Loss of NUS1 in Drosophila led to reduced climbing ability, dopamine levels, dopaminergic neurons, and induced apoptosis.

    Conclusions:

    • De novo mutations are implicated in the pathogenesis of early onset Parkinson's disease.
    • NUS1 is identified as a novel candidate gene for Parkinson's disease.
    • Functional evidence supports NUS1's role in neurodegeneration relevant to PD.